Feb 17 2025 32 mins 5
Stay up-to-date on the latest advancements in antipsychotic medications and how they’re shaping the management of mental health conditions. This episode highlights new formulations, expanded indications, and emerging treatment trends that every pharmacist should know. Don’t miss the chance to enhance your expertise and improve patient care!
HOST
Joshua Davis Kinsey, PharmD
VP, Education
CEimpact
GUEST
Katelynn Mayberry, PharmD
Clinical Assistant Professor of Pharmacy Practice
Mercer University College of Pharmacy
REFERENCE
The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia. https://psychiatryonline.org/doi/10.1176/appi.ajp.2020.177901
Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)
CPE INFORMATION
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Recall recent advancements in antipsychotic medications, including new formulations and expanded therapeutic indications.
2. Identify key considerations for pharmacists in optimizing the use of updated antipsychotic treatments to improve patient outcomes.
0.05 CEU/0.5 Hr
UAN: 0107-0000-25-031-H01-P
Initial release date: 2/17/2025
Expiration date: 2/17/2026
Additional CPE details can be found here.
